Sarah Rutherford
Weill Cornell Medicine
Sarah Rutherford
Weill Cornell Medicine
Dr. Rutherford is Assistant Professor at Weill Cornell Medicine. Her Lymphoma Clinical Research Mentoring Program (LCRMP) project seeks to use imaging to tailor treatment plans for diffuse large B-cell lymphoma (DLBCL) patients. Most DLBCL patients with advanced stage disease receive a combination therapy called R-CHOP [rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone], given in six cycles every three weeks.
Topic: Diagnostic and Management Approaches for High-Risk Aggressive B-cell Lymphomas.
Sarah Rutherford
Weill Cornell Medicine
Laurie Sehn
The University of British Columbia
Laurie Sehn
The University of British Columbia
Dr Laurie Sehn is currently Clinical Professor with the BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, Canada. She has been a medical oncologist and clinical investigator at BC Cancer since 1998, and is currently the Chair of the Lymphoma Tumour Group. Dr Sehn graduated from McGill Medical School, Montreal, Canada and received her training in Internal Medicine at Columbia Presbyterian Medical Center, Columbia University, New York, USA.
Topic: What’s new for relapsed lymphoma.
Laurie Sehn
The University of British Columbia
UK OFFICE
US OFFICE